The study found that the adverse reactions in pediatric patients were similar in type and frequency to those seen in adult patients. The overall frequency of adverse events in Period A was 70 percent (36% had infections). The most common infections were upper respiratory tract infection and nasopharyngitis. Serious side effects included leukemia, chickenpox, ovarian cyst, disease flare, and joint deterioration.



















